Tag: EPS26 Prescription Drug Policy
Tag: EPS26 Prescription Drug Policy
-
Sunshine Week: ALEC Model Policies to Foster Transparency
As America commemorates 250 years of independence, ALEC proudly joins the nation in celebrating Sunshine Week, an initiative dedicated to promoting open government and ensuring public access to information. ALEC…
-
Myths vs. Facts: 340B Revisited
Myth #1: 340B Doesn’t Cost Taxpayers Any Money Fact: The 340B program drives up drug prices for everyone. A recent IQVIA study shows that state employee health…
-
Brooklyn Roberts Testimony in Kansas: 340B Impact on States, Taxpayers, and the Health Care System
ALEC Health And Human Services Senior Task Force Director Brooklyn Roberts was recently invited to testify before the Kansas State Legislature Special Committee on Pharmaceutical Studies regarding the federal 340B…
-
How the 340B Drug Program Is Driving Up Costs For States and Employers
The federal 340B drug program was created with a straightforward mission—to provide steeply discounted drugs to safety net hospitals and clinics that serve large populations of low-income and uninsured…
-
340B Transparency and Accountability Act
Section 1 Definitions: (1) “340B Covered Entity” means an entity described in 42 U.S.C. 256b(a)(4)(L) through 42 U.S.C. 256b(a)(4)(O) that: a. is authorized to participate in the federal 340B…
-
Myths vs. Facts: 340B, Drug Discounts, and Price Fixing
What is 340B? There is significant controversy surrounding 340B, a program created by Congress in 1992 to help hospitals and certain other health care providers that serve large numbers of…
-
Price-Fixing Prescription Drugs Will Cost Us in Cures
Prescription drug pricing has been a recent topic of media scrutiny, and is said to be the reason for the high cost of healthcare in the United States. The result…